NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球Sunitinib malate市場規模調查:按類型(純度:> 99%,> 98%,> 97%),按應用(胰腺神經內分泌腫瘤,腎癌,胃腸道間質瘤),按地區(預測)2021-2027)

Global Sunitinib malate market Size study, by Type (Purity: >99%, Purity: >98%, Purity: >97%), by Application (Pancreatic Neuroendocrine Tumors, Kidney Cancer, Gastrointestinal stromal tumor) and Regional Forecasts 2021-2027

出版商 Bizwit Research & Consulting LLP 商品編碼 1014082
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
全球Sunitinib malate市場規模調查:按類型(純度:> 99%,> 98%,> 97%),按應用(胰腺神經內分泌腫瘤,腎癌,胃腸道間質瘤),按地區(預測)2021-2027) Global Sunitinib malate market Size study, by Type (Purity: >99%, Purity: >98%, Purity: >97%), by Application (Pancreatic Neuroendocrine Tumors, Kidney Cancer, Gastrointestinal stromal tumor) and Regional Forecasts 2021-2027
出版日期: 2021年06月11日內容資訊: 英文
簡介

全球Sunitinib malate市場預計在 2021-2027 年期間以健康的增長率增長。

Sunitinib malate是一種小分子藥物,已被證明可以阻斷多種受體 (RTK) 的幾種酪氨酸激□。

由於其潛在的抗腫瘤活性,Sunitinib malate被公認為抑制細胞增殖和血管生成的有效藥物。舒尼替尼膠囊用於治療胰腺神經內分泌腫瘤、腎癌和胃腸道間質瘤 (GIST)。舒尼替尼是首個同時被批准用於兩種適應症的癌症治療藥物:腎細胞癌和伊馬替尼耐藥的胃腸道間質瘤(GIST)。

全球Sunitinib malate市場主要受到技術進步和胰腺癌患病率上升的推動。胰腺癌患病率的增加是全球Sunitinib膠囊市場的主要驅動力。根據美國癌症協會的數據,2017 年將有超過 56,000 名美國人被診斷出患有胰腺癌,其中超過 42,000 人預計將死於胰腺癌。胰腺腫瘤相對難以接近,因此比其他腫瘤更難診斷和切除。因此,蘋果酸舒尼替尼膠囊越來越多地用於治療胰腺癌。然而,在 2021-2027 年的預測期內,研發 (R&D) 的高成本和高可持續性預計將阻礙市場增長。

本報告調查了全球Sunitinib malate市場,按類型、應用、地區和進入市場的公司概況提供了市場概況、趨勢。

目錄

第 1 章執行摘要

第 2 章全球蘋果酸舒尼替尼市場的定義和範圍

第 3 章全球蘋果酸舒尼替尼市場動態

  • Sunitinib malate市場影響分析(2019-2027)

第 4 章全球Sunitinib malate市場行業分析

  • 波特的 5 力模型
  • PEST 分析
  • 招商招商模式
  • 分析師建議和結論

第 5 章全球Sunitinib malate市場,按類型

  • 市場快照
  • 全球Sunitinib malate市場,按類型:性能潛力分析
  • 全球Sunitinib malate市場的估計和預測,按類型:2018-2027(10億美元)
  • Sunitinib malate市場,細分市場分析
    • 純度:超過 99%
    • 純度:超過 98%
    • 純度:超過 97%

第 6 章全球Sunitinib malate市場,按應用

  • 市場快照
  • 全球Sunitinib malate市場,按應用:性能潛力分析
  • 全球Sunitinib malate市場的估計和預測,按應用:2018-2027(10億美元)
  • Sunitinib malate市場,細分市場分析
    • 胰腺神經內分泌腫瘤
    • 腎癌
    • 胃腸道間質瘤

第 7 章全球Sunitinib malate市場,區域分析

  • 區域市場快照
  • 北美
    • 美國
    • 加拿大
  • 歐洲快照
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他
  • 亞太地區快照
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他
  • 拉丁美洲快照
    • 巴西
    • 墨西哥
  • 其他

第 8 章競爭信息

  • 頂級市場策略
  • 公司簡介
    • Pfizer Incorporation
    • Topcarepharm
    • Njfirstpharm
    • J&K Scientific
    • Targetmol
    • Synthland Ltd
    • Teva Pharmaceutical Industries Ltd.
    • Astellas Pharma, Inc.
    • Dendreon Corporation
    • Ferring Pharmaceuticals, Inc.

第 9 章調查使用

  • 調查使用
    • 數據挖掘
    • 分析
    • 市場報價
    • 驗證
    • 出版
  • 調查屬性
  • 調查的前提
目錄

Global Sunitinib malate market is valued at approximately XX in 2020 and is anticipated to grow with a healthy growth rate of more than XX over the forecast period 2021-2027. Sunitinib malate is a small-molecule medication that has been shown to block several tyrosine kinases in different receptors (RTKs). Sunitinib is recognized as an effective drug in suppressing cell proliferation and angiogenesis due to its potential antineoplastic action. Sunitinib capsules are used to treat pancreatic neuroendocrine tumors, renal cancer, and gastrointestinal stromal tumors (GIST). Sunitinib was the first cancer treatment to be licensed for two indications at the same time: renal cell carcinoma and imatinib-resistant gastrointestinal stromal tumor (GIST). The global sunitinib malate market is primarily driven by technological advancements and the rising prevalence of pancreatic cancer. Pancreatic cancer's rising prevalence is a primary driver of the worldwide sunitinib capsules market. According to the American Cancer Society, over 56,000 Americans will be diagnosed with pancreatic cancer in 2017, with over 42,000 of them anticipated to die by pancreatic cancer. Pancreatic tumors are more difficult to diagnose and remove than other tumors due to their relative inaccessibility. As a result, sunitinib malate capsules are increasingly being used to treat pancreatic cancers. However, higher cost of research and development(R&D), and high cost of sutent may impede market growth over the forecast period of 2021-2027.

The regional analysis of the global Sunitinib malate market is considered for the key regions such as North America Asia Pacific, , Latin America, Europe, and Rest of the World (ROW). North America is the leading region across the world in terms of market share due to rising prevalence of pancreatic cancer in the region. Whereas Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to growing awareness about pancreatic cancer in developing economies such as India, China, and others.

Major market player included in this report are:

Pfizer Incorporation

Topcarepharm

Njfirstpharm

J&K Scientific

Targetmol

Synthland Ltd

Teva Pharmaceutical Industries Ltd.

Astellas Pharma, Inc.

Dendreon Corporation

Ferring Pharmaceuticals, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Purity: >99%

Purity: >98%

Purity: >97%

By Application:

Pancreatic Neuroendocrine Tumors

Kidney Cancer

Gastrointestinal stromal tumor

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018-19

Base year - 2019-2020

Forecast period - 2021 to 2027.

Target Audience of the Global Sunitinib malate market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
    • 1.2.1. Sunitinib malate market , by Region, 2019-2027 (USD Billion)
    • 1.2.2. Sunitinib malate market , by Type, 2019-2027 (USD Billion)
    • 1.2.3. Sunitinib malate market , by Application, 2019-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Sunitinib malate market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Sunitinib malate market Dynamics

  • 3.1. Sunitinib malate market Impact Analysis (2019-2027)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of pancreatic cancer
      • 3.1.1.2. Increasing prevalence of pancreatic neuroendocrine tumours
    • 3.1.2. Market Restraint
      • 3.1.2.1. High cost of Sutent
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increase in Pharmaceutical R&D Spending

Chapter 4. Global Sunitinib malate market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Sunitinib malate market , by Type

  • 5.1. Market Snapshot
  • 5.2. Global Sunitinib malate market by Type , Performance - Potential Analysis
  • 5.3. Global Sunitinib malate market Estimates & Forecasts by Type 2018-2027 (USD Billion)
  • 5.4. Sunitinib malate market , Sub Segment Analysis
    • 5.4.1. Purity: >99%
    • 5.4.2. Purity: >98%
    • 5.4.3. Purity: >97%

Chapter 6. Global Sunitinib malate market , by Application

  • 6.1. Market Snapshot
  • 6.2. Global Sunitinib malate market by Application, Performance - Potential Analysis
  • 6.3. Global Sunitinib malate market Estimates & Forecasts by Application 2018-2027 (USD Billion)
  • 6.4. Sunitinib malate market , Sub Segment Analysis
    • 6.4.1. Pancreatic Neuroendocrine Tumors
    • 6.4.2. Kidney Cancer
    • 6.4.3. Gastrointestinal stromal tumor

Chapter 7. Global Sunitinib malate market , Regional Analysis

  • 7.1. Sunitinib malate market , Regional Market Snapshot
  • 7.2. North America Sunitinib malate market
    • 7.2.1. U.S. Sunitinib malate market
      • 7.2.1.1. Type breakdown estimates & forecasts, 2018-2027
      • 7.2.1.2. Application breakdown estimates & forecasts, 2018-2027
    • 7.2.2. Canada Sunitinib malate market
  • 7.3. Europe Sunitinib malate market Snapshot
    • 7.3.1. U.K. Sunitinib malate market
    • 7.3.2. Germany Sunitinib malate market
    • 7.3.3. France Sunitinib malate market
    • 7.3.4. Spain Sunitinib malate market
    • 7.3.5. Italy Sunitinib malate market
    • 7.3.6. Rest of Europe Sunitinib malate market
  • 7.4. Asia-Pacific Sunitinib malate market Snapshot
    • 7.4.1. China Sunitinib malate market
    • 7.4.2. India Sunitinib malate market
    • 7.4.3. Japan Sunitinib malate market
    • 7.4.4. Australia Sunitinib malate market
    • 7.4.5. South Korea Sunitinib malate market
    • 7.4.6. Rest of Asia Pacific Sunitinib malate market
  • 7.5. Latin America Sunitinib malate market Snapshot
    • 7.5.1. Brazil Sunitinib malate market
    • 7.5.2. Mexico Sunitinib malate market
  • 7.6. Rest of The World Sunitinib malate market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. Pfizer Incorporation
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Topcarepharm
    • 8.2.3. Njfirstpharm
    • 8.2.4. J&K Scientific
    • 8.2.5. Targetmol
    • 8.2.6. Synthland Ltd
    • 8.2.7. Teva Pharmaceutical Industries Ltd.
    • 8.2.8. Astellas Pharma, Inc.
    • 8.2.9. Dendreon Corporation
    • 8.2.10. Ferring Pharmaceuticals, Inc.

Chapter 9. Research Application

  • 9.1. Research Application
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Sunitinib malate market , report scope
  • TABLE 2. Global Sunitinib malate market estimates & forecasts by region 2018-2027 (USD Billion)
  • TABLE 3. Global Sunitinib malate market estimates & forecasts by Type 2018-2027 (USD Billion)
  • TABLE 4. Global Sunitinib malate market estimates & forecasts by Application 2018-2027 (USD Billion)
  • TABLE 5. Global Sunitinib malate market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 6. Global Sunitinib malate market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 7. Global Sunitinib malate market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 8. Global Sunitinib malate market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 9. Global Sunitinib malate market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 10. Global Sunitinib malate market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 11. Global Sunitinib malate market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 12. Global Sunitinib malate market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 13. Global Sunitinib malate market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 14. Global Sunitinib malate market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 15. Global Sunitinib malate market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 16. Global Sunitinib malate market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 17. Global Sunitinib malate market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 18. Global Sunitinib malate market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 19. Global Sunitinib malate market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 20. Global Sunitinib malate market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 21. U.S. Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 22. U.S. Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 23. U.S. Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 24. Canada Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 25. Canada Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 26. Canada Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 27. UK Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 28. UK Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 29. UK Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 30. Germany Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 31. Germany Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 32. Germany Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 33. France Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 34. France Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 35. France Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 36. Spain Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 37. Spain Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 38. Spain Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 39. Italy Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 40. Italy Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 41. Italy Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 42. ROE Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 43. ROE Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 44. ROE Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 45. China Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 46. China Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 47. China Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 48. India Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 49. India Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 50. India Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 51. Japan Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 52. Japan Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 53. Japan Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 54. Australia Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 55. Australia Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 56. Australia Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 57. South Korea Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 58. South Korea Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 59. South Korea Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 60. ROPAC Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 61. ROPAC Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 62. ROPAC Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 63. Brazil Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 64. Brazil Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 65. Brazil Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 66. Mexico Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 67. Mexico Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 68. Mexico Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 69. ROLA Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 70. ROLA Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 71. ROLA Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 72. ROW Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 73. ROW Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 74. ROW Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 75. List of secondary sources used in the study of global Sunitinib malate market .
  • TABLE 76. List of primary sources used in the study of global Sunitinib malate market .
  • TABLE 77. Years considered for the study.
  • TABLE 78. Exchange rates considered.

LIST OF FIGURES

List of figures

  • FIG 1. Global Sunitinib malate market , research methodology
  • FIG 2. Global Sunitinib malate market , market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Sunitinib malate market , key trends 2019
  • FIG 5. Global Sunitinib malate market , growth prospects 2020-2027
  • FIG 6. Global Sunitinib malate market , porters 5 force model
  • FIG 7. Global Sunitinib malate market , pest analysis
  • FIG 8. Global Sunitinib malate market , value chain analysis
  • FIG 9. Global Sunitinib malate market by segment, 2018 & 2027 (USD Billion)
  • FIG 10. Global Sunitinib malate market by segment, 2018 & 2027 (USD Billion)
  • FIG 11. Global Sunitinib malate market by segment, 2018 & 2027 (USD Billion)
  • FIG 12. Global Sunitinib malate market by segment, 2018 & 2027 (USD Billion)
  • FIG 13. Global Sunitinib malate market by segment, 2018 & 2027 (USD Billion)
  • FIG 14. Global Sunitinib malate market by segment, 2018 & 2027 (USD Billion)
  • FIG 15. Global Sunitinib malate market by segment, 2018 & 2027 (USD Billion)
  • FIG 16. Global Sunitinib malate market by segment, 2018 & 2027 (USD Billion)
  • FIG 17. Global Sunitinib malate market , regional snapshot 2018 & 2027
  • FIG 18. North America Sunitinib malate market 2018 & 2027 (USD Billion)
  • FIG 19. Europe Sunitinib malate market 2018 & 2027 (USD Billion)
  • FIG 20. Asia-Pacific Sunitinib malate market 2018 & 2027 (USD Billion)
  • FIG 21. Latin America Sunitinib malate market 2018 & 2027 (USD Billion)
  • FIG 22. Global Sunitinib malate market , company market share analysis (2019)